Zobrazeno 1 - 10
of 839
pro vyhledávání: '"Prednisone/therapeutic use"'
Autor:
Maher Albitar, Hong Zhang, Andre Goy, Zijun Y. Xu-Monette, Govind Bhagat, Carlo Visco, Alexandar Tzankov, Xiaosheng Fang, Feng Zhu, Karen Dybkaer, April Chiu, Wayne Tam, Youli Zu, Eric D. Hsi, Fredrick B. Hagemeister, Jooryung Huh, Maurilio Ponzoni, Andrés J. M. Ferreri, Michael B. Møller, Benjamin M. Parsons, J. Han van Krieken, Miguel A. Piris, Jane N. Winter, Yong Li, Bing Xu, Ken H. Young
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 2, Pp 1-9 (2022)
Blood Cancer Journal, 12
Blood Cancer Journal, 12, 2
Albitar, M, Zhang, H, Goy, A, Xu-Monette, Z Y, Bhagat, G, Visco, C, Tzankov, A, Fang, X, Zhu, F, Dybkaer, K, Chiu, A, Tam, W, Zu, Y, Hsi, E D, Hagemeister, F B, Huh, J, Ponzoni, M, Ferreri, A J M, Møller, M B, Parsons, B M, van Krieken, J H, Piris, M A, Winter, J N, Li, Y, Xu, B & Young, K H 2022, ' Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms ', Blood Cancer Journal, vol. 12, no. 2, 25 . https://doi.org/10.1038/s41408-022-00617-5
Albitar, M, Zhang, H, Goy, A H, Xu-Monette, Z, Bhagat, G, Visco, C, Tzankov, A, Fang, X, Zhu, F, Dybkaer, K, Chiu, A, Tam, W, Zu, Y, Hsi, E D, Hagemeister, F B, Huh, J, Ponzoni, M, Ferreri, A J M, Moller, M, Parsons, B M, Van Krieken, J H J M, Piris, M A, Winter, J N, Li, Y, Xu, B & Young, K H 2021, ' Determining Clinical Course of Diffuse Large B-Cell Lymphoma Using Targeted Transcriptome and Machine Learning Algorithms ', Blood, vol. 138, no. Suppl. 1, 2395 . https://doi.org/10.1182/blood-2021-148841
Blood Cancer Journal
Blood Cancer Journal, 12
Blood Cancer Journal, 12, 2
Albitar, M, Zhang, H, Goy, A, Xu-Monette, Z Y, Bhagat, G, Visco, C, Tzankov, A, Fang, X, Zhu, F, Dybkaer, K, Chiu, A, Tam, W, Zu, Y, Hsi, E D, Hagemeister, F B, Huh, J, Ponzoni, M, Ferreri, A J M, Møller, M B, Parsons, B M, van Krieken, J H, Piris, M A, Winter, J N, Li, Y, Xu, B & Young, K H 2022, ' Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms ', Blood Cancer Journal, vol. 12, no. 2, 25 . https://doi.org/10.1038/s41408-022-00617-5
Albitar, M, Zhang, H, Goy, A H, Xu-Monette, Z, Bhagat, G, Visco, C, Tzankov, A, Fang, X, Zhu, F, Dybkaer, K, Chiu, A, Tam, W, Zu, Y, Hsi, E D, Hagemeister, F B, Huh, J, Ponzoni, M, Ferreri, A J M, Moller, M, Parsons, B M, Van Krieken, J H J M, Piris, M A, Winter, J N, Li, Y, Xu, B & Young, K H 2021, ' Determining Clinical Course of Diffuse Large B-Cell Lymphoma Using Targeted Transcriptome and Machine Learning Algorithms ', Blood, vol. 138, no. Suppl. 1, 2395 . https://doi.org/10.1182/blood-2021-148841
Blood Cancer Journal
Introduction: Multiple studies have demonstrated that diffuse large B-cell lymphoma (DLBCL) can be divided into subgroups based on their biology. However, these biological subgroups overlap clinically. While R-CHOP (rituximab, cyclophosphamide, doxor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c9ae5e528b2a56ac4958ad97d7f7744
https://doaj.org/article/93888a803eda4609ab485bda57596d9c
https://doaj.org/article/93888a803eda4609ab485bda57596d9c
Autor:
Lasse Hjort Jakobsen, Andreas Kiesbye Øvlisen, Marianne Tang Severinsen, Joachim Bæch, Kristian Hay Kragholm, Ingrid Glimelius, Anne Ortved Gang, Judit Mészáros Jørgensen, Henrik Frederiksen, Christian Bjørn Poulsen, Michael Roost Clausen, Per Trøllund Pedersen, Robert Schou Pedersen, Christian Torp-Pedersen, Sandra Eloranta, Tarec Christoffer El-Galaly
Publikováno v:
Jakobsen, L H, Øvlisen, A K, Severinsen, M T, Bæch, J, Kragholm, K H, Glimelius, I, Gang, A O, Jørgensen, J M, Frederiksen, H, Poulsen, C B, Clausen, M R, Pedersen, P T, Pedersen, R S, Torp-Pedersen, C, Eloranta, S & El-Galaly, T C 2022, ' Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark ', Blood Cancer Journal, vol. 12, no. 1, 16 . https://doi.org/10.1038/s41408-022-00614-8
Blood Cancer Journal
Blood Cancer Journal, Vol 12, Iss 1, Pp 1-7 (2022)
Jakobsen, L H, Øvlisen, A K, Severinsen, M T, Bæch, J, Kragholm, K H, Glimelius, I, Gang, A O, Jørgensen, J M, Frederiksen, H, Poulsen, C B, Clausen, M R, Pedersen, P T, Pedersen, R S, Torp-Pedersen, C, Eloranta, S & El-Galaly, T C 2022, ' Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark ', Blood Cancer Journal, vol. 12, 16 . https://doi.org/10.1038/s41408-022-00614-8
Jakobsen, L H, Ovlisen, A K, Severinsen, M T, Baech, J, Kragholm, K H, Glimelius, I, Gang, A O, Jorgensen, J M, Frederiksen, H, Poulsen, C B, Clausen, M R, Pedersen, P T, Pedersen, R S, Torp-Pedersen, C, Eloranta, S & El-Galaly, T C 2022, ' Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark ', Blood Cancer Journal, vol. 12, no. 1, 16 . https://doi.org/10.1038/s41408-022-00614-8
Blood Cancer Journal
Blood Cancer Journal, Vol 12, Iss 1, Pp 1-7 (2022)
Jakobsen, L H, Øvlisen, A K, Severinsen, M T, Bæch, J, Kragholm, K H, Glimelius, I, Gang, A O, Jørgensen, J M, Frederiksen, H, Poulsen, C B, Clausen, M R, Pedersen, P T, Pedersen, R S, Torp-Pedersen, C, Eloranta, S & El-Galaly, T C 2022, ' Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark ', Blood Cancer Journal, vol. 12, 16 . https://doi.org/10.1038/s41408-022-00614-8
Jakobsen, L H, Ovlisen, A K, Severinsen, M T, Baech, J, Kragholm, K H, Glimelius, I, Gang, A O, Jorgensen, J M, Frederiksen, H, Poulsen, C B, Clausen, M R, Pedersen, P T, Pedersen, R S, Torp-Pedersen, C, Eloranta, S & El-Galaly, T C 2022, ' Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark ', Blood Cancer Journal, vol. 12, no. 1, 16 . https://doi.org/10.1038/s41408-022-00614-8
For most patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL), R-CHOP immunochemotherapy leads to complete remission and 60–70% of patients remain progression-free after 5 years. Given a median age of 65, it is relevant to disentangl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7611d7de63550fde1e34623f58f2393f
https://vbn.aau.dk/ws/files/461184201/Jakobsen_et_al._2022_._Patients_in_complete_remission_after_R_CHOP_like_therapy_for_diffuse_large_B_cell_lymphoma_have_limited_excess_use_of_health_care_services_in_Denmark.pdf
https://vbn.aau.dk/ws/files/461184201/Jakobsen_et_al._2022_._Patients_in_complete_remission_after_R_CHOP_like_therapy_for_diffuse_large_B_cell_lymphoma_have_limited_excess_use_of_health_care_services_in_Denmark.pdf
Autor:
Thierry Gil, Peter Schatteman, Marylene Clausse, Jan Van Haverbeke, Joanna Van Erps, Jeroen Mebis, Wim Demey, Marika Rasschaert, Dirk Schrijvers, Lionel D'Hondt, Els Everaert, W. Wynendaele, Bertrand Filleul, Sylvie Rottey, Filip Van Aelst, Joanna Vermeij, Fransien Van Hende, Patrick Werbrouck, Jean-Charles Goeminne, Charles Van Praet, Gino Pelgrims, Nicolaas Lumen, Jolanda Verheezen, Jean Pascal Machiels, Denis Schallier
Publikováno v:
Clinical Genitourinary Cancer
Individual patients' survival varies greatly in metastatic castration-resistant prostate cancer. Retrospective analysis of 368 patients treated with docetaxel and starting abiraterone acetate revealed 5 adverse prognostic factors: hemoglobin < 12 g/d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05307a24c7cbd336f7da4e0f7a8dd3be
https://doi.org/10.1016/j.clgc.2017.01.019
https://doi.org/10.1016/j.clgc.2017.01.019
Autor:
Marjon Elfferich, Celine Hendriks, J. Møller, J. de Vries, Ulrich Costabel, Marjolein Drent, Mareye Voortman, Francesco Bonella
Publikováno v:
Voortman, M, Hendriks, CMR, Elfferich, M, Bonella, F, Møller, J, De Vries, J, Ulrich, C & Drent, M 2019, ' The Burden of Sarcoidosis Symptoms from a Patient Perspective ', Lung, vol. 197, no. 2, pp. 155–161 . https://doi.org/10.1007/s00408-019-00206-7
Lung, 197(2), 155. Springer New York
Lung
Lung, 197, 155-161. Springer New York
Lung, 197(2), 155. Springer New York
Lung
Lung, 197, 155-161. Springer New York
Purpose The clinical manifestations of sarcoidosis vary widely, depending on the intensity of the inflammation and the organ systems affected. Hence, sarcoidosis patients may suffer from a great variety of symptoms. The aim of this study was to compa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::241d863ff5697548f15439aeb3db97bd
https://pure.au.dk/ws/files/195676639/Voortman2019_Article_TheBurdenOfSarcoidosisSymptoms.pdf
https://pure.au.dk/ws/files/195676639/Voortman2019_Article_TheBurdenOfSarcoidosisSymptoms.pdf
Autor:
Maja Bech Juul, Pernille Hammershoej Jensen, Lars Munksgaard, Michael Roost Clausen, Lene Meldgaard Knudsen, Thomas Stauffer Larsen, Henrik Frederiksen, Tarec Christoffer El-Galaly, Joachim Baech, Helene Bjoerg Kristensen, Donika Haziri, Rebecca Valentin, Lene Schurmann, Sonja Wehberg, Andriette Dessau-Arp, Henriette Engberg
Publikováno v:
Juul, M B, Jensen, P H, Engberg, H, Wehberg, S, Dessau-Arp, A, Haziri, D, Kristensen, H B, Baech, J, Schurmann, L, Clausen, M R, Valentin, R, Knudsen, L M, Munksgaard, L, El-Galaly, T C, Frederiksen, H & Larsen, T S 2018, ' Treatment strategies and outcomes in diffuse large B-cell lymphoma among 1011 patients aged 75 years or older : A Danish population-based cohort study ', European Journal of Cancer, vol. 99, pp. 86-96 . https://doi.org/10.1016/j.ejca.2018.05.006
BACKGROUND: Optimal treatment strategy for the oldest patients with diffuse large B-cell lymphoma (DLBCL) remains controversial, as this group often is precluded from clinical trials, and population-based studies are limited.METHODS: All Danish DLBCL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78d3703f738aa55dd6da4b67b9076b33
https://pure.au.dk/portal/da/publications/treatment-strategies-and-outcomes-in-diffuse-large-bcell-lymphoma-among-1011-patients-aged-75-years-or-older(0ce58589-61ae-4448-974d-07103d539027).html
https://pure.au.dk/portal/da/publications/treatment-strategies-and-outcomes-in-diffuse-large-bcell-lymphoma-among-1011-patients-aged-75-years-or-older(0ce58589-61ae-4448-974d-07103d539027).html
Autor:
Anette Bygum, Kristina Lings
Publikováno v:
Lings, K & Bygum, A 2015, ' Linear IgA Bullous Dermatosis : A Retrospective Study of 23 Patients in Denmark ', Acta Dermatovenereologica, vol. 95, no. 4, pp. 466-471 . https://doi.org/10.2340/00015555-1990
Linear IgA bullous dermatosis (LAD) is an autoimmune, chronic bullous disease affecting primarily young children and adults. Studies on LAD are relatively sparse and from Scandinavia we could only find a few case reports. Therefore we decided to cond
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fea62fd3a4badda5d2274eab7bc1d09e
https://doi.org/10.2340/00015555-1990
https://doi.org/10.2340/00015555-1990
Autor:
van Eggermond, Anna M, Schaapveld, Michael, Janus, Cécile Pm, de Boer, Jan Paul, Krol, Augustinus Dg, Zijlstra, Josée M, van der Maazen, Richard Wm, Kremer, Leontien C, van Leerdam, Monique E, Louwman, Marieke Wj, Visser, Otto, De Bruin, Marie L, Aleman, Berthe Mp, van Leeuwen, Flora E, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
British Journal of Cancer
British Journal of Cancer, 117, 3, pp. 306-314
Van Eggermond, A M, Schaapveld, M, Janus, C P M, De Boer, J P, Krol, A D, Zijlstra, J M, Van Der Maazen, R W M, Kremer, L C, Van Leerdam, M E, Louwman, M W J, Visser, O, De Bruin, M L, Aleman, B M P & Van Leeuwen, F E 2017, ' Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors ', British Journal of Cancer, vol. 117, no. 3, pp. 306-314 . https://doi.org/10.1038/bjc.2017.177
British Journal of Cancer, 117(3), 306-314. Nature Publishing Group
British journal of cancer, 117(3), 306-314. Nature Publishing Group
British Journal of Cancer, 117(3), 306-314
British Journal of Cancer, 117(3), 306. Nature Publishing Group
van Eggermond, A M, Schaapveld, M, Janus, C P, de Boer, J P, Krol, A D, Zijlstra, J M, van der Maazen, R W, Kremer, L C, van Leerdam, M E, Louwman, M W, Visser, O, De Bruin, M L, Aleman, B M & van Leeuwen, F E 2017, ' Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors ', B J C, vol. 117, no. 3, pp. 306-314 . https://doi.org/10.1038/bjc.2017.177
British Journal of Cancer, 117, 306-314
British Journal of Cancer, 117, 3, pp. 306-314
Van Eggermond, A M, Schaapveld, M, Janus, C P M, De Boer, J P, Krol, A D, Zijlstra, J M, Van Der Maazen, R W M, Kremer, L C, Van Leerdam, M E, Louwman, M W J, Visser, O, De Bruin, M L, Aleman, B M P & Van Leeuwen, F E 2017, ' Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors ', British Journal of Cancer, vol. 117, no. 3, pp. 306-314 . https://doi.org/10.1038/bjc.2017.177
British Journal of Cancer, 117(3), 306-314. Nature Publishing Group
British journal of cancer, 117(3), 306-314. Nature Publishing Group
British Journal of Cancer, 117(3), 306-314
British Journal of Cancer, 117(3), 306. Nature Publishing Group
van Eggermond, A M, Schaapveld, M, Janus, C P, de Boer, J P, Krol, A D, Zijlstra, J M, van der Maazen, R W, Kremer, L C, van Leerdam, M E, Louwman, M W, Visser, O, De Bruin, M L, Aleman, B M & van Leeuwen, F E 2017, ' Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors ', B J C, vol. 117, no. 3, pp. 306-314 . https://doi.org/10.1038/bjc.2017.177
British Journal of Cancer, 117, 306-314
Contains fulltext : 177780.pdf (Publisher’s version ) (Open Access) BACKGROUND: Hodgkin lymphoma (HL) survivors are at increased risk of second malignancies, but few studies have assessed colorectal cancer (CRC) risk after HL treatment. We assessed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7595fd6daf279e7e1e99120d7057f813
https://hdl.handle.net/1887/115418
https://hdl.handle.net/1887/115418
Publikováno v:
Revista Brasileira de Oftalmologia, Volume: 75, Issue: 1, Pages: 64-66, Published: FEB 2016
RESUMO A Síndrome de Tolosa Hunt é uma doença rara, cuja etiopatogenia é desconhecida. Apresenta-se como uma oftalmoplegia dolorosa de um ou mais nervos cranianos oculomotores, que regride espontaneamente e responde bem ao tratamento com corticoi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______608::6d7e83499ee0cc82901ffbd3eed249bf
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802016000100064&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802016000100064&lng=en&tlng=en
Treat to target (T2T) strategies have proved to be useful in several chronic disorders, including Rheumatoid Arthritis. In systemic lupus erythematosus (SLE), T2T strategy has been proposed in order to control disease activity, improve health-related
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3932::2c418a0d470d668dae072dd19e1fbe21
https://hdl.handle.net/20.500.12866/5253
https://hdl.handle.net/20.500.12866/5253
Autor:
Caroline Hastings, Judith F. Margolin, Debra L. Kearney, Valérie Anne Mclin, Jennifer R. Rushton, Amy Kun Pass
Publikováno v:
Journal of Pediatric Hematology / Oncology, Vol. 30, No 12 (2008) pp. 976-980
This is the first description in which the diagnosis of vanishing bile duct syndrome (VBDS) preceded the diagnosis of Hodgkin disease (HD) by several months, and for which patients received modifications to modern MOPP-ABV chemotherapy with successfu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::315e6ccfb72e4e1a5b5f91b35aa34635
https://doi.org/10.1097/mph.0b013e31818b37c4
https://doi.org/10.1097/mph.0b013e31818b37c4